Measuring these genetic signatures could enable doctors to refine a individual&39.

Measuring these genetic signatures could enable doctors to refine a individual's prognosis, select appropriate treatments, as well as perhaps offer new remedies that focus on these shared genetic abnormalities. It's exciting: the CU Cancer Middle has internationally recognized experience in both of these cancers – lung and bladder – and with this research we could actually find what’s effectively a common denominator between both of these main tobacco-related cancers. We realize that many cancers hurry through the cell routine to replicate themselves quicker than does healthy cells, and today we see that a few of the same processes are in function in both lung and bladder cancers, says Dan Theodorescu, MD, PhD, director of the CU Cancer Middle and lead writer of the scholarly study.The study, which has run for more than fifteen years and recently was funded for another five, is supported by the National Institute of Alcohol and Alcoholism Abuse, part of the National Institutes of Health. The new work that may explore these associations further in youth has been funded by the National Institute on SUBSTANCE ABUSE, also a portion of the NIH. In their ninth calendar year in the study, participants completed the MicroCog Assessment of Cognitive Function, a well-established standard battery of lab tests that assess short-term memory space, immediate and delayed tale recall, verbal analogies, mathematical reasoning and visual-spatial processing.